Position in ACLX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$9,261,839
-$5,968,358 QoQ
Shares Held
80,664
-65.5% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. ACLX ranks #40 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in ACLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,261,839 | 80,664 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $15,230,197 | 233,592 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $32,784,088 | 399,319 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $21,688,617 | 329,364 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $22,546,325 | 343,694 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $26,421,927 | 344,529 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $38,889,770 | 465,690 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $24,643,989 | 446,530 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $31,143,307 | 447,783 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $7,724,878 | 139,187 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $684,948 | 19,090 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $4,616,867 | 146,011 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $564,345 | 18,317 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $389,883 | 12,585 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $232,503 | 12,387 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $80,419 | 4,448 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $71,193 | 5,078 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||